What are the causes of hypercalcemia in a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Hypercalcemia in Children

Hypercalcemia in children is most commonly PTH-independent (suppressed PTH) rather than PTH-dependent, with causes varying significantly by age—sepsis dominates in neonates while genetic syndromes, endocrine disorders, and malignancies become more prevalent in older children. 1, 2

Classification Framework

Pediatric hypercalcemia should be systematically categorized based on parathyroid hormone (PTH) levels into two major groups 1, 3:

PTH-Independent Hypercalcemia (Suppressed PTH)

This is more common in children than PTH-dependent causes 1:

Genetic/Congenital Causes:

  • Idiopathic infantile hypercalcemia (IIH): Most common in the first 2 years of life, often resolves during childhood but lifelong calcium metabolism abnormalities may persist 4, 1, 3
  • Williams-Beuren syndrome: Presents with increased calcium absorption from the gut (mechanism unknown), symptomatic hypercalcemia peaks in first 2 years, associated with dehydration, hypercalciuria, and nephrocalcinosis 4, 1, 3, 5
  • Hypophosphatasia: Inborn error of metabolism 3, 5
  • Other inborn errors of metabolism 1, 3

Acquired Causes:

  • Hypervitaminosis D: Excessive vitamin D supplementation 1
  • Granulomatous disorders: Including sarcoidosis 1
  • Endocrinopathies: Congenital adrenal hyperplasia, Addison's disease, fat necrosis 1, 2
  • Malignancy-related: Tumors producing PTH-related peptide or calcitriol 1
  • Immobilization: Particularly in adolescents 5
  • Milk-alkali syndrome 5

PTH-Dependent Hypercalcemia (Normal or Elevated PTH)

Genetic/Familial Causes:

  • Familial hypocalciuric hypercalcemia (FHH): Autosomal dominant CASR mutations, can be homozygous with milder mutations 1, 2, 6
  • Neonatal severe primary hyperparathyroidism (NSHPT): Severe form requiring urgent intervention 1, 3
  • Familial isolated primary hyperparathyroidism 1
  • Multiple endocrine neoplasia (MEN) syndromes: MEN1 and MEN2 with hyperparathyroidism developing at specific ages based on genotype—screening begins at 11 years for "high risk" and 16 years for "moderate risk" RET alleles 4, 1
  • Jansen's metaphyseal chondrodysplasia: Activating PTH receptor mutations 3, 5

Acquired Causes:

  • Primary hyperparathyroidism (PHPT): Parathyroid adenomas or hyperplasia 1, 6
  • Tertiary hyperparathyroidism: Associated with chronic renal failure or hypophosphatemic rickets treatment 1
  • Maternal hypocalcemia: Causes neonatal hyperparathyroidism 1, 3
  • Extracorporeal membrane oxygenation (ECMO): In neonates 1

Age-Specific Considerations

Neonates and infants (0-2 years) have the highest frequency of severe hypercalcemia, accounting for 42% of sustained cases 2:

  • Sepsis is the leading cause in neonates, representing 41% of all neonatal hypercalcemia cases 2
  • Idiopathic infantile hypercalcemia and Williams syndrome present most commonly in this age group 4, 1, 3
  • Maternal factors (hypocalcemia) and dietary causes must be evaluated 3

Older children and adolescents have different etiologies with lower overall frequency inversely related to age 2:

  • Primary hyperparathyroidism becomes more common 1, 6
  • Malignancy-related hypercalcemia increases 1
  • Immobilization-related hypercalcemia can occur 5

Critical Diagnostic Pitfalls

Sustained vs. transient hypercalcemia: Only 63.3% of children with severe hypercalcemia (≥2.90 mmol/L) have sustained elevation (≥2 consecutive days); transient elevations may not require extensive workup 2

Williams syndrome surveillance: Serum calcium should be monitored every 4-6 months until 2 years of age, then every 2 years thereafter, as lifelong abnormalities in calcium and vitamin D metabolism persist even after symptomatic hypercalcemia resolves 4

MEN2 screening protocols: Hyperparathyroidism screening with serum calcium begins at age-specific intervals based on RET genotype risk stratification—"high risk" at 11 years, "moderate risk" at 16 years, with "highest risk" codon 918 variants not associated with PHPT 4

Frequency in clinical practice: Sustained severe hypercalcemia affects approximately 1 in 500 children in general hospital settings, making thorough investigation essential for all cases 2

References

Research

Hypercalcemic Disorders in Children.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2017

Research

Frequency and aetiology of hypercalcaemia.

Archives of disease in childhood, 2016

Research

Genetic causes of neonatal and infantile hypercalcaemia.

Pediatric nephrology (Berlin, Germany), 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rare Causes of Hypercalcemia.

Endocrinology and metabolism clinics of North America, 2021

Research

Hypercalcemia in children and adolescents.

Current opinion in pediatrics, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.